en · de · es · fr · pt
thymosin-alpha-1-notes.peptides6908.com › Wiki › Background And Biological Role — Worked Examples

Background And Biological Role — Worked Examples

By Editorial Desk · published 2026-05-12 · last reviewed 2026-06-06 · Wiki

Everything below concerns lyophilized powder. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Last reviewed on 2026-06-06. Where a claim depends on a specific study, the study is described rather than over-claimed.

Background and Biological Role

The compound has been investigated as an adjunct in chronic viral hepatitis and as a vaccine adjuvant, with results that vary by study design and population. Regulators in some countries have approved a synthetic form for specific indications, while other agencies have not. Whether the peptide produces consistent clinical benefit across diverse patient groups is still an open question, and many trials have been small. Its status is therefore best described as investigational in many contexts and established only narrowly.

The name itself causes confusion, because several unrelated thymic peptides share the thymosin label. Thymosin beta-4, for example, is a different molecule with different functions. Naming conventions in the literature also mix descriptive research terms with assigned nonproprietary names, so a reader should confirm which entity a given paper addresses. Clarifying that point is usually the first step in interpreting any claim about this peptide.

Thymosin alpha-1 is a short peptide of 28 amino acid residues first described in the 1970s as a component of thymic extracts. Its N-terminal residue carries an acetyl group, and the sequence is highly conserved across mammalian species. The peptide is not encoded as a standalone gene product; it is released by proteolytic cleavage from the N-terminus of prothymosin alpha, a larger acidic nuclear protein. That precursor relationship places it within a broader family of thymic and immune-associated peptides that have been studied for decades.

Identity and Molecular Background

The peptide occurs naturally in thymic tissue and has been detected in serum and other biological fluids. Reported concentrations are low, and reliable measurement generally requires immunoassay or mass spectrometry with an enrichment step. It is released from a larger precursor, prothymosin alpha, by proteolytic cleavage, although the enzymes involved are not fully characterized. Whether circulating levels reflect thymic output specifically remains an open question.

Thymosin alpha 1 is a 28-amino-acid peptide first isolated from thymosin fraction 5, a bovine thymic extract. Its sequence begins with an acetylated serine residue and carries a high proportion of acidic residues, so the molecule has a net negative charge near neutral pH. Despite the shared name, it is unrelated in sequence to the thymosin beta family. Synthetic material prepared by solid-phase peptide synthesis is identical in sequence to the natural peptide.

Several names appear in the literature for this peptide, including thymalfasin and the abbreviation T-alpha-1. Naming conventions differ among research articles, regulatory documents, and supplier catalogs, which complicates literature searches. Both synthetic and recombinant production routes yield a peptide with the same 28-residue sequence as the thymic isolate. Because the thymosin label also covers unrelated peptides, sources should be compared by sequence rather than by name alone.

Thymosin-alpha-1 at a glance

PropertyValueNotes
Residue count28 amino acidsAcetyl group on the first residue
Approximate molecular mass3108 daltonsCalculated from the consensus sequence
OriginCleavage product of prothymosin alphaNot encoded as a separate gene product
Primary research focusImmune modulationStudied in viral hepatitis and as a vaccine adjuvant
Common synonymsThymalfasin, Tα1, thymosin alpha 1Thymalfasin is the assigned nonproprietary name

Analytical Methods and Storage Stability

Quality control for thymosin alpha-1 focuses on identity, purity, and potency. Identity is confirmed by mass spectrometry and amino acid analysis, while purity is assessed by chromatography with limits on related substances and residual solvents. Potency assays may use cell-based immune readouts, but these are not standardized across laboratories. Regulatory status differs by jurisdiction; no product is approved in the United States for clinical use, whereas some other countries register injectable forms for specific indications.

Quantifying thymosin alpha-1 in a sample usually relies on reverse-phase high-performance liquid chromatography. The peptide lacks strong chromophores, so detection often occurs at 214 nm, where the peptide backbone absorbs. Mass spectrometry provides confirmatory identification and can detect sequence variants or truncations. Immunoassays have been used in biological matrices, but they may cross-react with related fragments. For purity assessment, chromatographic peak area gives the main component percentage, while mass accuracy verifies molecular identity.

Related pages on this site

Storage, Handling, and Analytical Methods

Long-term storage is generally at minus twenty degrees Celsius or colder, preferably desiccated and protected from light. Lyophilized material is more stable than reconstituted solution, which degrades faster at room temperature. Stability depends on pH, ionic strength, and the presence of oxidising agents. Published stability data for the peptide are limited, so storage claims in catalogues should be treated as general guidance rather than measured guarantees. Freeze-thaw cycles are kept to a minimum.

Identity and purity are normally confirmed by reversed-phase high-performance liquid chromatography and mass spectrometry. The expected mass for the acetylated 28-residue peptide is close to 3108 daltons, and a mass shift indicates a modification or truncation. Peptide mapping after enzymatic digestion can resolve sequence-level questions. Counter-ion content, water content, and residual solvents are separate quality attributes that a certificate of analysis may or may not report. Aggregation is monitored by size-exclusion chromatography when relevant.

Thymosin alpha-1 is supplied as a lyophilized powder in most research settings. The solid dissolves readily in water and in common aqueous buffers, and it is typically reconstituted shortly before use. Solutions are clear and colourless at ordinary working concentrations. Because the peptide is hygroscopic, weighing and reconstitution are usually performed with minimal exposure to ambient air. Aliquots are prepared to avoid repeated freeze-thaw cycles, and working solutions are kept cold.

免疫调节机制与信号

临床研究将Tα1用于慢性病毒感染、肿瘤辅助治疗和疫苗佐剂等场景。部分试验报告了免疫学指标改善,但临床终点获益在不同研究中并不一致。系统综述指出,研究间在人群、剂量和联合方案上差异较大,难以汇总结论。因此,Tα1的确切临床地位仍属开放问题,需要更多高质量随机对照试验来澄清。其机制研究也需从体外实验向体内模型推进。

胸腺素α1对免疫系统的影响涉及多种细胞类型。研究表明,它可促进未成熟T细胞向成熟T细胞分化,并增强T细胞对抗原刺激的增殖反应。树突状细胞在Tα1存在下表达更高水平的共刺激分子,从而更有效地呈递抗原。此外,自然杀伤细胞的活性也观察到上升。这些效应并非直接杀伤病原体,而是调节宿主免疫应答的强度与方向。

Supporting material

Proinsulin is the prohormone precursor to insulin made in the beta cells of the Pancreatic Islets, specialized regions of the pancreas. In humans, proinsulin is encoded by the INS gene. The pancreatic islets only secrete between 1% and 3% of proinsulin intact. However, because proinsulin has a longer half life than insulin, it can account for anywhere from 5–30% of the insulin-like structures circulating in the blood. There are higher concentrations of proinsulin after meals and lower levels when a person is fasting. Additionally, while proinsulin and insulin have structural differences, proinsulin does demonstrate some affinity for the insulin receptor. Due to the relative similarities in structure, proinsulin can produce between 5% and 10% of the metabolic activity similarly induced by insulin. Proinsulin is the final single chain protein structure secreted by cells before cleavage into mature insulin. Proinsulin was discovered by Professor Donald F. Steiner of the University of Chicago in 1967.

This infuriated American colonists and led to the Boston Tea Party, where 90,000 pounds of EIC tea were dumped into the Boston Harbor. As news spread, tea was destroyed throughout the colonies. In Greenwich New Jersey for example, chests of tea were burned in Market Square. As a consequence of these acts and the American revolution (1765–1791), tea drinking became seen as unpatriotic. One article in the Boston Gazette on 15 August, 1768 stated: “Let us abjure the poisonous baneful plant and its odious infusion – poisonous and odious, I mean, not on account of its physical qualities but on account of the political diseases and death that are connected with every particle of it.” Boycotts of tea by revolutionary patriots led to an increase in consumption of other beverages, such as coffee, yaupon tea, or herbal teas infused with peppermint, sage or dandelions. In spite of the distaste for tea that was fueled by the revolution, tea continued to be used by Americans, especially after the war. For example, George Washington regularly had tea for breakfast and dinner, in the English fashion. American merchants Samuel Shaw and Robert Morris sent the first merchant ship to China (the Empress of China) and soon Chinese tea was being shipped to America by American merchant vessels.

Medical staff at remote hospitals and clinics place orders with Zipline, a fulfillment operator receives this order and prepares the medical products into a special delivery package with a parachute. A Zipline flight operator then packs the medical products into a drone and performs pre-flight checks. The drone is then launched with a supercapacitor-powered electric catapult launcher which accelerates it to 67 miles per hour (108 km/h) in 0.33 seconds. The drone cruises at 101 km/h (63 mph) at an altitude of 80–120 metres (260–390 ft) above ground level, while a remote pilot at each distribution center monitors all drones in flight. The drone descends to 20–35 metres (66–115 ft) before dropping the package under a paper "Drogue" parachute. A payload can land within a 5 m (16 ft) diameter landing zone. The drone then returns to the distribution center and lands by its tail hook catching an arresting gear, similar to airplanes landing on an aircraft carrier. A Zipline distribution center can deliver medical supplies reliably anywhere within 100 km (62 mi), even accounting for mountainous terrain and severe weather.

Dean Robinson (born 9 September 1974) is an Australian fitness coach who has worked with a variety of both AFL and NRL clubs. Better known as The Weapon, Robinson is notable for his intense training methods which were criticised following a spate of soft-tissue injuries at Essendon in the second half of the 2012 AFL season. Prior to his work as a professional fitness coach, Robinson showed a passion for rodeo. Acting the position of both a steer wrestler and a rodeo clown, Robinson proved a versatile competitor and went all the way to the World Steer Wrestling Association titles in 1997. He also spent several years training other rodeo athletes, before later branching out into additional sports. Before his association with a long string of clubs, Robinson worked at the NSW Institute of Sport. His subsequent transition into the NRL was sparked by his brother Trent Robinson, who had been employed in a variety of coaching roles at several clubs. Beginning in 2005, Robinson worked with the Manly Sea Eagles. Spending two years at the club, Robinson implemented a far more scientific approach to training than was previously in place. Robinson’s contribution to the club’s improved performance did not go unnoticed, and in 2006 AFL clubs also began to express interest in his services. This soon culminated in the Geelong Football Club hiring him for the 2007 season. Robinson left Geelong to join the new Gold Coast Football Club in their inaugural season. After a year there, he moved back to Melbourne and began working for the Essendon Football Club.

Hypotension not due to arrhythmia Bradycardia Accelerated idioventricular rhythm Elderly Ehlers–Danlos syndromes; efficiency of local anesthetics can be reduced Pseudocholinesterase deficiency Intra-articular infusion (this is not an approved indication and can cause chondrolysis) Porphyria, especially acute intermittent porphyria; lidocaine has been classified as porphyrogenic because of the hepatic enzymes it induces, although clinical evidence suggests it is not. Bupivacaine is a safe alternative in this case. Impaired liver function – people with lowered hepatic function may have an adverse reaction with repeated administration of lidocaine because the drug is metabolized by the liver. Adverse reactions may include neurological symptoms (e.g. dizziness, nausea, muscle twitches, vomiting, or seizures).

Sources: en.wikipedia.org

Supporting material

=== Ojibwe === The longest word in the Ojibwe language is miinibaashkiminasiganibiitoosijiganibadagwiingweshiganibakwezhigan (66 letters), meaning "blueberry pie". This literally translates to "blueberry cooked to jellied preserve that lies in layers in which the face is covered in bread".

==== Newsreel tradition ==== The newsreel tradition is important in documentary film. Newsreels at this time were sometimes staged but usually re-enactments of events that had already happened, not attempts to steer events as they were happening. For instance, much of the battle footage from the early 20th century was staged; the cameramen would usually arrive on site after a major battle and re-enact scenes to film them.

Other signature items at Roy Rogers are the Gold Rush chicken sandwich (a fried chicken breast with bacon, a slice of Monterey Jack cheese, and a honey-based BBQ sauce) and the Double-R Bar Burger (a cheeseburger with ham). The side items featured at Roy Rogers are french fries, baked potatoes, mashed potatoes with gravy, and baked beans. Seasonal items that select Roy Rogers locations occasionally offer include the beer-battered cod sandwich and platter.

=== Creation of Animal Models === Intracerebroventricular injection has been used to inject drugs that induce a diseased state to create animal models for a variety of diseases. Of these, Alzheimer's disease (AD) animal models are heavily represented in the literature. ICV injection of Streptozotocin has been used to create a metabolic model of Alzheimer's disease. This protocol works by damaging the control level of cerebral glucose metabolism to mimic Alzheimer's disease symptoms. An early sign of AD is glucose hypometabolism and impaired insulin signaling has been seen in AD patients. Streptozotocin has also largely been used to create diabetes animal models, by injecting either intravenously or intraperitoneally. These ICV injections result in models for the sporadic Alzheimer's disease (sAD) form, rather than familial. A characteristic of sAD is an insulin-resistant brain state (IRBS). Streptozotocin is a beta-cytotoxic drug and by injecting it directly into the cerebral ventricles, the treated mice develop symptoms that align with sAD symptoms in humans. Some of these symptoms include IRBS-associated memory impairment, glucose hypometabolism, oxidative stress, and neurodegeneration. More recently, a model for AD that represents both familial and sporadic AD has emerged. In the clinic, as well as independent experiments, an increase in amyloid beta (Aβ) levels in the brain has been seen to cause Alzheimer-like symptoms. To create an animal model of AD, Aβ can be injected using ICV injection.

== Genome == An. gambiae s.s. genomes have been sequenced three times, once for the M strain, once for the S strain, and once for a hybrid strain. Currently, ~90 miRNA have been predicted in the literature (38 miRNA officially listed in miRBase) for An. gambiae s.s. based upon conserved sequences to miRNA found in Drosophila. Holt et al., 2002 and Neafsey et al., 2016 find transposable elements to be ~13% of the genome, similar to Drosophila melanogaster (also in Diptera). However they find the proportion of TE types to be very different from D. melanogaster with approximately the same composition of long terminal repeat retrotransposons, non-long terminal repeat retrotransposons and DNA transposons. These proportions are believed to be representative of the genus. The genetics and genomics of sex chromosomes have been discovered and studied by Windbichler et al., 2007 and Galizi et al., 2014 (a Physarum polycephalum homing endonuclease which destroys X chromosomes), Windbichler et al., 2008 and Hammond et al., 2016 (methods to reduce the female population), Windbichler et al., 2011 (trans from yeast), Bernardini et al., 2014 (a method to increase the male population), Kyrou et al., 2018 (a female necessary exon and a homing endonuclease to drive it), Taxiarchi et al., 2019 (sex chromosome dynamics in general) and Simoni et al., 2020 (an X chromosome destroying site specific nuclease). See § Gene drive below for their applications. An. gambiae has a high degree of polymorphism.

Sources: en.wikipedia.org

Frequently asked questions

Is thymosin alpha-1 a hormone?

It is usually classified as an immunomodulatory peptide rather than a classical hormone. It derives from the larger protein prothymosin alpha and acts mainly on immune cells. The thymosin label covers a group of distinct peptides, so the naming can be misleading.

How does it differ from thymosin beta-4?

The two share a family name but have different sequences, sizes, and functions. Thymosin beta-4 is a 43-residue peptide associated with actin binding and cell migration. Thymosin alpha-1 is a 28-residue peptide linked mainly to immune signaling.

Why is the term thymalfasin also used?

Thymalfasin is the assigned international nonproprietary name for the synthetic 28-residue peptide. Thymosin alpha-1 is the descriptive research name for the same molecule. Which term appears depends on the context and the regulatory document.

What is thymosin alpha 1?

It is a 28-amino-acid peptide originally purified from a bovine thymic extract and later produced synthetically. It is studied mainly for its effects on immune cell function.

Network